MedTrace Logo

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

NCT05845632 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 965

Last updated 2023-08-16

No results posted yet for this study

Summary

The purpose of this study is to investigate the association between time to treatment (defined as date of pathological diagnosis to date of start treatment) and disease free survival in patients with high risk cutaneous squamous cell carcinoma in the head-neck region.

Conditions

  • Carcinoma, Squamous Cell
  • Skin Cancer
  • Carcinoma, Squamous Cell, Skin
  • Carcinoma, Squamous Cell of Head and Neck
  • Recurrence
  • Metastasis

Interventions

OTHER

Treatment

Patients were treated with surgery, radiotherapy or surgery with postoperative radiotherapy.

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • N Kelleners-Smeets, MD, PhD · Maastricht University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-05-01
Completion
2023-10-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05845632 on ClinicalTrials.gov